Evidence map›Paper›PMID 34468554›Full record

ArticleArquivos brasileiros de oftalmologia

Effect of central serous chorioretinopathy patients by covering sick eye for 48 hours.

Hongwei Zhao, Changyu Qiu, Yuanyuan Shi, Yan Zhang, Chuang Nie, Yubo Gong, Jun Zhao, Ling Luo

Abstract read
In one paragraph

Article in Arquivos brasileiros de oftalmologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Hongwei ZhaoDepartment of Ophthalmology, The 306th Hospital of People's Liberation Army, Beijing, China.
Changyu QiuDepartment of Ophthalmology, The 306th Hospital of People's Liberation Army, Beijing, China.
Yuanyuan ShiDepartment of Ophthalmology, The 306th Hospital of People's Liberation Army, Beijing, China.
Yan ZhangDepartment of Ophthalmology, The Seventh Medical Center of Chinese People's Liberation Army General Hospital, China.
Chuang NieDepartment of Ophthalmology, The 306th Hospital of People's Liberation Army, Beijing, China.
Yubo GongDepartment of Ophthalmology, The 306th Hospital of People's Liberation Army, Beijing, China.
Jun ZhaoDepartment of Ophthalmology, The 306th Hospital of People's Liberation Army, Beijing, China.
Ling LuoDepartment of Ophthalmology, The 306th Hospital of People's Liberation Army, Beijing, China.ORCID 0000-0001-6773-5042

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess the effect of continuously covering the sick eye affected with central serous chorioretinopathy for 48 h. Methods: This retrospective, case-control study involved 32 central serous chorioretinopathy patients categorized in the treatment group composed of 17 sick eye that received continuous covering treatment for 48 h with a medical gauze and the observation group composed of 15 of these patients who were followed up. None of the patients received any other treatments or medications. The logarithm of the minimal angle of resolution (logMAR) best-corrected visual acuity, macular retinal thickness, and the root mean square value of the amplitude density in the first ring of multifocal electroretinogram were examined before and after the 48-h treatment.

resultsAfter the continuous treatment, the logMAR best-corrected visual acuities were 0.31 ± 0.18 and 0.56 ± 0.37 in the treatment and observation groups, respectively (p=0.019). The macular retinal thicknesses were 461 ± 43 µm and 498 ± 50 µm in the treatment and observation groups, respectively (p=0.032). The root mean square values of the amplitude density in the first ring of multifocal electroretinogram were 32.5 ± 5.3 nV/deg2 and 26.6 ± 4.3 nV/deg2 in the treatment and observation groups, respectively (p=0.002).

conclusionsThe continuous application of the covering treatment for 48 h on the sick eye showed positive outcomes with respect to the best-corrected visual acuity, macular retinal thickness, and macular retina functions in the treatment of central serous chorioretinopathy.

Indexed as

Central Serous ChorioretinopathyCase-Control StudiesFluorescein AngiographyHumansRetrospective StudiesTomography, Optical CoherenceVisual Acuity

Identifiers

PMID34468554
PMCPMC11884371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.